International Journal of Molecular Sciences (Apr 2020)

Increased Protein <i>S</i>-Glutathionylation in Leber’s Hereditary Optic Neuropathy (LHON)

  • Lei Zhou,
  • James Chun Yip Chan,
  • Stephanie Chupin,
  • Naïg Gueguen,
  • Valérie Desquiret-Dumas,
  • Siew Kwan Koh,
  • Jianguo Li,
  • Yan Gao,
  • Lu Deng,
  • Chandra Verma,
  • Roger W Beuerman,
  • Eric Chun Yong Chan,
  • Dan Milea,
  • Pascal Reynier

DOI
https://doi.org/10.3390/ijms21083027
Journal volume & issue
Vol. 21, no. 8
p. 3027

Abstract

Read online

Leber’s hereditary optic neuropathy (LHON, MIM#535000) is the most common form of inherited optic neuropathies and mitochondrial DNA-related diseases. The pathogenicity of mutations in genes encoding components of mitochondrial Complex I is well established, but the underlying pathomechanisms of the disease are still unclear. Hypothesizing that oxidative stress related to Complex I deficiency may increase protein S-glutathionylation, we investigated the proteome-wide S-glutathionylation profiles in LHON (n = 11) and control (n = 7) fibroblasts, using the GluICAT platform that we recently developed. Glutathionylation was also studied in healthy fibroblasts (n = 6) after experimental Complex I inhibition. The significantly increased reactive oxygen species (ROS) production in the LHON group by Complex I was shown experimentally. Among the 540 proteins which were globally identified as glutathionylated, 79 showed a significantly increased glutathionylation (p S-glutathionylation is mainly known to be responsible for protein loss of function, and molecular dynamics simulations and 3D structure predictions confirmed such deleterious impacts on adenine nucleotide translocator 2 (ANT2), by weakening its affinity to ATP/ADP. Our study reveals a broad impact throughout the cell of Complex I-related LHON pathogenesis, involving a generalized protein stress response, and provides a therapeutic rationale for targeting S-glutathionylation by antioxidative strategies.

Keywords